These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16882106

  • 1. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
    Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF.
    J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
    [Abstract] [Full Text] [Related]

  • 2. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.
    Eur J Gen Pract; 2007 Aug; 13(2):89-91. PubMed ID: 17534745
    [Abstract] [Full Text] [Related]

  • 3. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype.
    Lee JH, Lee YK, Kim EK, Kim TH, Huh JW, Kim WJ, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Sheen SS, Kim N, Seo JB, Oh YM, Lee SD.
    Respir Med; 2010 Apr; 104(4):542-9. PubMed ID: 19926461
    [Abstract] [Full Text] [Related]

  • 4. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

  • 5. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z, Kucharewicz I, Bodzenta-Lukaszyk A.
    Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
    [Abstract] [Full Text] [Related]

  • 6. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 7. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
    van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C.
    Am J Respir Crit Care Med; 2002 Nov 15; 166(10):1358-63. PubMed ID: 12406823
    [Abstract] [Full Text] [Related]

  • 8. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
    Umeda N, Yoshikawa T, Kanazawa H, Hirata K, Fujimoto S.
    Respirology; 2008 May 15; 13(3):346-52. PubMed ID: 18399855
    [Abstract] [Full Text] [Related]

  • 9. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P.
    Thorax; 2005 Mar 15; 60(3):193-8. PubMed ID: 15741434
    [Abstract] [Full Text] [Related]

  • 10. Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD.
    Sukisaki T, Senjyu H, Oishi K, Rikitomi N, Ariyoshi K.
    Physiother Theory Pract; 2008 Mar 15; 24(4):255-63. PubMed ID: 18574751
    [Abstract] [Full Text] [Related]

  • 11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 15; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 12. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr 15; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar 15; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 14. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
    Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW.
    Respirology; 2006 Sep 15; 11(5):598-602. PubMed ID: 16916333
    [Abstract] [Full Text] [Related]

  • 15. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep 15; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
    Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J.
    Thorax; 2005 Dec 15; 60(12):992-7. PubMed ID: 16227327
    [Abstract] [Full Text] [Related]

  • 17. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP, Calverley PM.
    COPD; 2008 Jun 15; 5(3):147-52. PubMed ID: 18568838
    [Abstract] [Full Text] [Related]

  • 18. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L, Bertella E, La Piana GE, Boni E, Redolfi S, Tantucci C.
    Respiration; 2008 Jun 15; 76(1):61-8. PubMed ID: 18319586
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug 15; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 20. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A, Ward NS.
    Med Health R I; 2002 Feb 15; 85(2):52-5. PubMed ID: 11881166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.